Solis v. Millennium Pharmaceuticals, Inc. et al

Filing 188

ORDER signed by District Judge Morrison C. England, Jr on 5/2/19 ORDERING that Defendants Schering-Plough Corp., Merck & Co., and Millennium Pharmaceuticals, Inc. shall file their anticipated responsive motions to the Third Amended Complaint no later than June 10, 2019. Plaintiff Relator Frank Solis shall file his opposition(s) to Defendants' responsive motions no later than July 17, 2019. Defendants shall file their replies in support of their responsive motions no later than August 1, 2019. (Kaminski, H)

UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF CALIFORNIA
UNITED STATES OF AMERICA ex rel.
FRANK SOLIS,
PLAINTIFF,
v.
MILLENNIUM PHARMACEUTICALS,
INC., SCHERING-PLOUGH CORP., and
MERCK & CO.,
DEFENDANTS.

CASE NO. 2:09-cv-03010-MCE-JFM
ORDER GRANTING STIPULATION
REGARDING MOTION TO DISMISS
THIRD AMENDED COMPLAINT
BRIEFING SCHEDULE
Amended Complaint to be filed: May 10, 2019
Current response date: May 24, 2019
New response date: June 10, 2019
Assigned to: Hon. Morrison C. England, Jr.
Location:
Courtroom 7, 14th Floor

The Court has reviewed and considered the Stipulation Regarding Motion to Dismiss
Third Amended Complaint Briefing Schedule filed by the parties to this action.
Good cause appearing, IT IS ORDERED that:
1.

Defendants

Schering-Plough

Corp.,

Merck

&

Co.,

and

Millennium

Pharmaceuticals, Inc. shall file their anticipated responsive motions to the Third Amended
Complaint no later than June 10, 2019;
2.

Plaintiff Relator Frank Solis shall file his opposition(s) to Defendants’ responsive

motions no later than July 17, 2019;
////
////
////
ORDER GRANTING STIPULATION REGARDING MOTION TO DISMISS THIRD AMENDED COMPLAINT
BRIEFING SCHEDULE
1

3.

Defendants shall file their replies in support of their responsive motions no later

than August 1, 2019; and
4.

The Court will hear the motions to dismiss on September 19, 2019, at 2:00 p.m..

IT IS SO ORDERED.
Dated: May 2, 2019

ORDER GRANTING STIPULATION REGARDING MOTION TO DISMISS THIRD AMENDED COMPLAINT
BRIEFING SCHEDULE
2